Clinitech Laboratory IPO Logo

Clinitech Laboratory IPO - GMP, Subscription, Price, Dates & Financial Details

25 July - 29 July 2024
SME BSE
Closed

Clinitech Laboratory IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a fixed price issue with a total issue size of ₹6 Crore, comprising a fresh issue of 6.02 Lakh equity shares aggregating to ₹5.78 Crore.

The Clinitech Laboratory IPO remained open for subscription from July 25, 2024, to July 29, 2024. The basis of allotment was finalized on July 30, 2024, and the company's shares were listed on BSE SME Platform on August 01, 2024.

The company had fixed the price at ₹96 per share, with a lot size of 1200 shares. Retail investors were required to make a minimum investment of ₹230,400 (based on the upper price band) to apply for one lot.

Bigshare Services Pvt Ltd served as the registrar to the issue. Inventure Merchant Banker Services Pvt Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.

With the successful completion of the IPO process, Clinitech Laboratory Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.

Issue Price
₹ 96
Lot Size
1200
Issue Size
₹5.78 Cr
Minimum Investment
₹ 230,400 (2400 Shares)
Listing Date
01 August 2024

Current GMP

₹65 (+67.71%)

Open Date 25 July, 2024
Close Date 29 July, 2024
Market Cap 21.91 Crore
Industry
Sector
Subscription 0x

*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.

About Clinitech Laboratory Limited

Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.

The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests.

Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.

The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.

As of May 31, 2024, the company employed 85 people in various departments.

Clinitech Laboratory IPO Promoters

Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak

Promoters Holding

Holding Pre Issue

83.63%

Holding Post Issue

61.56%

Clinitech Laboratory IPO Objective

The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:

  1. Expansion of Diagnostic Centres.

  2. General Corporate Purposes.

Clinitech Laboratory Limited Address / Contact Details

IPO Snapshot

Face Value₹10 per share
Issue Price ₹ 96
Lot Size1200
Issue Type
Sale Type
Fresh Issue₹ 5.78 Cr
Offer for Sale₹ 0.00 Cr
Total Issue Size₹ 5.78 Cr
Listing AtBSE
Industry
Sector
Retail Quota47.41%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

What is the Clinitech Laboratory IPO?

Clinitech Laboratory IPO is a with a total issue size of ₹5.78 crore. The Clinitech Laboratory IPO price band is ₹96 to 96 per share. The Clinitech Laboratory IPO subscription opens on Thu, Jul 25, 2024, and closes on Mon, Jul 29, 2024. The Clinitech Laboratory IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Clinitech Laboratory IPO.

When will the Clinitech Laboratory IPO open for subscription?

The Clinitech Laboratory IPO opens on Thu, Jul 25, 2024 and closes on Mon, Jul 29, 2024

What is Clinitech Laboratory IPO Price Band?

Clinitech Laboratory IPO Price Band is ₹96 to 96 per share.

What is Clinitech Laboratory IPO Lot Size?

Clinitech Laboratory IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹230400 based on the upper price band

What is the minimum investment for Clinitech Laboratory IPO?

The minimum investment for Clinitech Laboratory IPO is ₹230400, based on one lot of 1200 shares at the upper price band of ₹96 per share.

How to apply for Clinitech Laboratory IPO?

Investors can apply for the Clinitech Laboratory IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, Jul 29, 2024. The application amount remains blocked until the Clinitech Laboratory IPO allotment is finalized.

What is Clinitech Laboratory IPO Issue Size?

Clinitech Laboratory IPO issue size is ₹5.78 crores.

What is the Clinitech Laboratory IPO Allotment Date?

Clinitech Laboratory IPO allotment date is Tue, Jul 30, 2024.

Who is the Clinitech Laboratory IPO Registrar?

The registrar for Clinitech Laboratory IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Clinitech Laboratory IPO allotment status, refund processing, and other IPO-related information.

What is the Clinitech Laboratory IPO GMP?

The Clinitech Laboratory IPO GMP (Grey Market Premium) is ₹65 as of Thu, Aug 1, 2024. Based on the upper price band of ₹96 per share, the estimated Clinitech Laboratory IPO listing price is ₹161, indicating a potential listing gain of approximately 67.71% over the issue price.

Who is the Clinitech Laboratory IPO Lead Manager?

The book-running lead managers (BRLMs) for the Clinitech Laboratory IPO are . The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Clinitech Laboratory IPO Red Herring Prospectus (RHP).